Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Robert Charles Swanton

Director at Bicycle Therapeutics PLC (BCYC)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 6SEC BCYCBicycle Therapeutics PLC Sell 3,43115,782 held (−18%) $3.47 $12K -0.3%
Oct 6SEC BCYCBicycle Therapeutics PLC Sell Plan 10215,487 held (−1%) $8.55 $872 -59.5%
  • Sell

    Director Robert Charles Swanton sold $872 of BCYC at $8.55 — pre-scheduled 10b5-1 plan sale.